ArticleDigestive diseases and sciences2026
Impaired Bicarbonate Transport via SLC26A3 and CFTR Downregulation Promotes Mucous Cap Formation in Sessile Serrated Lesions.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- BEST4⁺ cells: a potential hub of intestinal ion transport and diarrhea manipulation.Advanced biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSessile serrated lesions (SSLs) are recognized as precursors in the serrated neoplastic pathway leading to microsatellite instability-high colorectal cancer. A hallmark feature of SSLs on endoscopic examination is the mucous cap.
aimsWe aimed to investigate the expression of the bicarbonate transporters SLC26A3 and CFTR in SSLs, using immunohistochemistry to elucidate their potential involvement in the pathogenesis of mucous cap formation.
methodsWe analysed 14 SSLs from 12 patients using formalin-fixed, paraffin-embedded tissue sections. Histochemical staining with high-iron diamine-Alcian blue (HID-AB) and immunohistochemistry for MUC2, MUC5AC, SLC26A3, and CFTR were conducted.
resultsIn normal colonic mucosa, MUC2 was strongly expressed in goblet cells, whereas MUC5AC was absent. SLC26A3 was expressed on the apical membrane and in the cytoplasm of surface epithelial and upper crypt cells, while CFTR was localized to the apical membrane of epithelial cells along the crypt axis. In SSLs, crypts showed architectural distortion with mucin retention in the dilated lumina and an overlying mucous cap. HID-AB staining revealed the presence of sulfomucins and sialomucins. Goblet cells coexpressed MUC2 and MUC5AC, with MUC2 showing broader and stronger expression. These mucins showed a partially distinct and mutually exclusive distribution. Notably, SLC26A3 and CFTR expression levels were markedly reduced or absent in SSLs.
conclusionSSLs showed a mixed acidic mucin phenotype and downregulated epithelial bicarbonate transporters. This may impair mucin expansion and hydration, leading to the formation of adhesive mucous caps, showing the potential link between defective bicarbonate transport and mucin physiology in SSLs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.